Cargando…

Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema

PURPOSE: Intravitreal anti-vascular endothelial growth factor (VEGF) agents are effective in the treatment of central involving diabetic macular oedema (DMO). Vitreoretinal interface abnormalities (VRIA) are common in patients with DMO, and the effect of these on the response to anti-VEGF treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Yun, Steel, David H. W., Habib, Maged S., Stubbing-Moore, Alex, Bajwa, Dalvir, Avery, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Retinal Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364245/ https://www.ncbi.nlm.nih.gov/pubmed/27957600 http://dx.doi.org/10.1007/s00417-016-3562-0

Ejemplares similares

Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy
por: Mikhail, Michael, et al.
Publicado: (2018)

Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY)
por: Sakamoto, Taiji, et al.
Publicado: (2021)

Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
por: Marquis, Liza-Marie, et al.
Publicado: (2020)

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment
por: Karst, Sonja G., et al.
Publicado: (2017)

A randomised controlled trial evaluating internal limiting membrane peeling forceps in macular hole surgery
por: Ferrara, Mariantonia, et al.
Publicado: (2022)

Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland
por: Zirpel, Johanna J., et al.
Publicado: (2021)

FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity
por: Monés, Jordi, et al.
Publicado: (2012)

Evaluation of non-exudative microcystoid macular abnormalities secondary to retinal vein occlusion
por: Francone, Anibal, et al.
Publicado: (2021)

Effect of intravitreal ranibizumab on the ocular circulation of the untreated fellow eye
por: Sugimoto, Masahiko, et al.
Publicado: (2017)

Disease-modifying effects of ranibizumab for central retinal vein occlusion
por: Huang, Jason M., et al.
Publicado: (2021)

Surgery-related characteristics, efficacy, safety and surgical team satisfaction of three-dimensional heads-up system versus traditional microscopic equipment for various vitreoretinal diseases
por: Zhao, Xin-yu, et al.
Publicado: (2022)

Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
por: Liu, Siyin, et al.
Publicado: (2022)

Choroidal thickness in lamellar macular holes
por: Kal, Magdalena, et al.
Publicado: (2020)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR
por: Freund, K. Bailey, et al.
Publicado: (2022)

Fixation behavior in macular dystrophy assessed by microperimetry
por: Chiang, Wei-Yu, et al.
Publicado: (2018)

A retrospective, multicenter study on the management of macular holes without residual internal limiting membrane: the refractory macular hole (ReMaHo) study
por: Lorenzi, Umberto, et al.
Publicado: (2022)

Fundus autofluorescence abnormalities can predict fluorescein angiography abnormalities in patients with chronic central serous chorioretinopathy
por: Mohabati, Danial, et al.
Publicado: (2023)

Near-infrared reflectance imaging of neovascular age-related macular degeneration
por: Theelen, Thomas, et al.
Publicado: (2009)

Effects of cataract surgery in Japanese patients with neovascular age-related macular degeneration
por: Nishiguchi, Fumi, et al.
Publicado: (2020)

Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration
por: Hörster, Robert, et al.
Publicado: (2010)

Long-term intraocular pressure changes after vitrectomy for epiretinal membrane and macular hole
por: Fujikawa, Masato, et al.
Publicado: (2013)

Vitrectomy and scleral imbrication in patients with myopic traction maculopathy and macular hole retinal detachment
por: Ando, Yoshimasa, et al.
Publicado: (2016)

Prechoroidal cleft thickness correlates with disease activity in neovascular age-related macular degeneration
por: Cozzi, Mariano, et al.
Publicado: (2021)

Anatomical and functional outcomes of pneumatic vitreolysis for treatment of vitreomacular traction with and without macular holes
por: Baumann, Carmen, et al.
Publicado: (2022)

Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathy
por: Schworm, Benedikt, et al.
Publicado: (2021)

The RAP study, report 4: morphological and topographical characteristics of multifocal macular neovascularization type 3
por: Haj Najeeb, Bilal, et al.
Publicado: (2021)

Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration treated with Aflibercept
por: Parvin, Parmis, et al.
Publicado: (2017)

Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration
por: Pellegrini, Marco, et al.
Publicado: (2020)

Comparison of swept-source versus spectral-domain optical coherence tomography angiography for detection of macular neovascularization
por: Lentzsch, Anna, et al.
Publicado: (2021)

Visualization of microaneurysms in macular telangiectasia type 1 on optical coherence tomography angiography before and after photocoagulation
por: Nakai, Mitsuko, et al.
Publicado: (2020)

Self-examination low-cost full-field OCT (SELFF-OCT) for patients with various macular diseases
por: von der Burchard, Claus, et al.
Publicado: (2020)

Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
por: Sugimoto, Masahiko, et al.
Publicado: (2022)

Early-switch versus late-switch in patients with diabetic macular edema: a cost-effectiveness study
por: Ruiz-Moreno, José M., et al.
Publicado: (2022)

Closure rates and patterns after light silicone oil tamponade for persistent full-thickness macular holes
por: Innauer, Felix, et al.
Publicado: (2023)

Optical coherence tomography angiography (OCT-A) in retinitis pigmentosa and macular dystrophy patients: a retrospective study
por: Deutsch, Sebastian, et al.
Publicado: (2022)

Improving morphological outcome in lamellar macular hole surgery by using highly concentrated autologous platelet-rich plasma
por: Hagenau, Felix, et al.
Publicado: (2021)

Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
por: Hanhart, Joel, et al.
Publicado: (2022)

A three-step approach to close refractory persistent macular holes: a releasing-closing-tapping approach
por: Su, Tong, et al.
Publicado: (2023)

Relationship between the distribution of intra-retinal hyper-reflective foci and the progression of intermediate age-related macular degeneration
por: Verma, Aditya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fr5hhba84ulu60hs53gadjh3ti